←
ESC WG on CPM Chairperson129 posts
ESC WG on CPM Chairperson avatar

ESC WG on CPM Chairperson

@WGCPMChair

Official X account of the @escardio Working Group on Coronary Pathophysiology & Microcirculation Chairperson. Posts by Edina Cenko and her team. #WGCPM_ESC

◷ Joined April 2025▧ 27 Photos and videos
Julia Grapsa avatar
⟳ ESC WG on CPM Chairperson retweeted
Julia Grapsa@JGrapsa·Sep 21

In this important piece at @ehj_ed #EHJ @ATycinska and @escardio nominating committee (where I was honoured to be a part of) emphasize the shortage of applications by female colleagues for ESC leadership positions ➡️ academic.oup.com/eurheartj/a… 🔥”The problem extends beyond leadership in professional societies and permeates the entire academic and clinical career pathway. Without targeted, measurable action, the gap will persist across generations of cardiologists. Tackling these systemic challenges requires coordinated, sustained, and accountable efforts from institutions, scientific societies, and individual leaders” 🔥 “To women colleagues at all career stages, we send a clear and unequivocal message: your expertise, perspectives, and lived experience are essential to the future of our Society and to the advancement of cardiovascular care in Europe. Your voice is needed not only at the bedside but also in decision-making” @Antonia_Sambola @weidinger_franz @EmmaSvennberg @OliviaManfrini @LindeCecilia @mrubini @WomenAs1

Post attachment
Elmir Omerovic avatar
⟳ ESC WG on CPM Chairperson retweeted
Elmir Omerovic@elmir1omerovic·Sep 3

Our trial is out in NEJM. SWITCH-SWEDEHEART randomised 7 Swedish regions, not individual patients, to a default prasugrel or a default ticagrelor policy in 17,095 patients with acute coronary syndrome undergoing PCI. At 1 year, prasugrel policy vs ticagrelor policy: MACE 11.1% vs 11.8%, adjusted OR 0.90 (95% CI 0.77 to 1.06) Major bleeding 4.2% vs 4.4%, adjusted OR 0.80 (0.64 to 0.99) A default prasugrel policy did not reduce ischaemic events. The estimate is a policy effect: the recommended agent was dispensed to 61% under the prasugrel policy and 76% under the ticagrelor policy, which attenuates the contrast. The trial ran inside SWEDEHEART for about EUR 25,000, and the shift to generic prasugrel saved considerably more than that while it ran. Randomised post-approval evaluation does not have to be expensive. doi.org/10.1056/NEJMoa260905…

ESC WG on Atherosclerosis & Vascular Biology Chair avatar
⟳ ESC WG on CPM Chairperson retweeted
ESC WG on Atherosclerosis & Vascular Biology Chair@ESCWGAVBChair·Jun 15

🫀 Proud to co-organise this FREE #ESCWGTalk with the @escardio @WGCPMChair 🗓️ 18 June 2026 | 16:00–17:00 CEST What’s New in Prediction & Prevention of Cardiovascular Complications in Diabetes 🎓 Open to all 🔗 : esc365.escardio.org/event/25… @EdinaCenko @eosto1 @liberale_luca

❤️Join us on 18 June 2026 (16:00–17:00 CEST) for a FREE @escardio Working Groups Talk co-organised by the @WGCPMChair & @ESCWGAVBChair 🎓 Open to all 🔗 Register: esc365.escardio.org/event/25… @EdinaCenko @eosto1 @escardio

Post attachment
Luca Liberale avatar
⟳ ESC WG on CPM Chairperson retweeted
Luca Liberale@liberale_luca·Jun 17

Tomorrow we’ll be discussing of Cardiovascular complications in diabetes together with the friends of the @WGCPMChair If you don’t want to miss this register now! Only few seats are left @escardio @ESCWGAVBChair @eosto1 @EdinaCenko

🫀 Proud to co-organise this FREE #ESCWGTalk with the @escardio @WGCPMChair 🗓️ 18 June 2026 | 16:00–17:00 CEST What’s New in Prediction & Prevention of Cardiovascular Complications in Diabetes 🎓 Open to all 🔗 : esc365.escardio.org/event/25… @EdinaCenko @eosto1 @liberale_luca